| Literature DB >> 19913446 |
Brigitte G Dorner1, Martin B Dorner, Xuefei Zhou, Corinna Opitz, Ahmed Mora, Steffen Güttler, Andreas Hutloff, Hans W Mages, Katja Ranke, Michael Schaefer, Robert S Jack, Volker Henn, Richard A Kroczek.
Abstract
The expression of the chemokine receptor XCR1 and the function of its ligand XCL1 (otherwise referred to as ATAC, lymphotactin, or SCM-1) remained elusive to date. In the present report we demonstrated that XCR1 is exclusively expressed on murine CD8(+) dendritic cells (DCs) and showed that XCL1 is a potent and highly specific chemoattractant for this DC subset. CD8(+) T cells abundantly secreted XCL1 8-36 hr after antigen recognition on CD8(+) DCs in vivo, in a period in which stable T cell-DC interactions are known to occur. Functionally, XCL1 increased the pool of antigen-specific CD8(+) T cells and their capacity to secrete IFN-gamma. Absence of XCL1 impaired the development of cytotoxicity to antigens cross-presented by CD8(+) DCs. The XCL1-XCR1 axis thus emerges as an integral component in the development of efficient cytotoxic immunity in vivo.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19913446 DOI: 10.1016/j.immuni.2009.08.027
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745